All substances for selected list or group
Question or comments? Contact substances@ec.gc.ca or 1-800-567-1999 (in Canada) or 819-938-3232. Results do not constitute endorsement of the substances or exemption from any other laws or regulations that may apply.
Results for list or group "Living Organisms on the Domestic Substances List"
Click here to perform another search
List or group: | Living Organisms on the Domestic Substances List |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant and non-replicative chimpanzee adenovirus-serotype 68 expressing a trivalent transgene coding for SARS-CoV-2 spike-nucleoprotein-polymerase (ChAd-TriCoV/Mac) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 20, September 25 2024, SOR/2024-173 |
Date published: | 2024-09-25 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant and non-replicative human adenovirus-serotype 5 expressing a trivalent transgene coding for SARS-CoV-2 spike-nucleoprotein-polymerase (Ad5-TriCoV/Mac) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 20, September 25 2024, SOR/2024-173 |
Date published: | 2024-09-25 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant and non-replicative single-stranded adeno-associated viral vector of serotype 2 expressing a soluble human CD59 gene (AAVCAGsCD59) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 9, April 24 2024, SOR/2024-56 |
Date published: | 2024-04-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant and replication-competent vaccine based on vesicular stomatitis virus with the VSV G-protein removed and replaced with the Ebola virus envelope glycoprotein (rVSVΔG-ZEBOV-GP) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 14, July 5 2023, SOR/2023-145 |
Date published: | 2023-07-05 |
Substance identifier: | 19349-7 |
Substance identifier (2): | |
Substance name: | Recombinant human autologous T lymphocyte expressing a chimeric antigen receptor for human B cell maturation antigen |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 153, No. 13, June 26 2019, SOR/2019-209 |
Date published: | 2019-06-26 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant human Herpes Simplex Virus encoding human Granulocyte Macrophage Colony-Stimulating Factor and the Gibbon Ape Leukaemia Virus surface GlycoProtein with R-sequence deleted |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 21, October 11, 2023, SOR/2023-201 |
Date published: | 2023-10-11 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant human mesenchymal stromal cells with a non-viral plasmid expressing the angiopoietin and acyloxyacyl hydrolase genes (GEM00220) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 156, No. 1, January 5 2022, SOR/2021-264 |
Date published: | 2022-01-05 |
Substance identifier: | 19624-2 |
Substance identifier (2): | |
Substance name: | Recombinant human T lymphocyte expressing a CD19-specific chimeric antigen receptor (CC-97540) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 156, No. 24, November 23, 2022, SOR/2022-233 |
Date published: | 2022-11-23 |
Substance identifier: | 19528-6 |
Substance identifier (2): | |
Substance name: | Recombinant human T lymphocytes expressing a CD19-specific chimeric antigen receptor |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 155, No. 17, August 18 2021, SOR/2021-180 |
Date published: | 2021-08-18 |
Substance identifier: | 19703-1 |
Substance identifier (2): | |
Substance name: | Recombinant human T lymphocytes expressing a CD19-specific chimeric antigen receptor (TBI-2001) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 9, April 24 2024, SOR/2024-56 |
Date published: | 2024-04-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant human T-cells transduced with a non-replicative lentiviral vector expressing a chimeric antigen receptor binding the human B-cell CD19 antigen (ALLO-501A) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 4, February 14 2024, SOR/2024-5 |
Date published: | 2024-02-14 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant human T-cells transduced with a non-replicative lentiviral vector expressing a chimeric antigen receptor binding the human B-cell maturation antigen (PHE885) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 9, April 24 2024, SOR/2024-56 |
Date published: | 2024-04-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant live-attenuated dengue virus serotype 1 modified from strain Western Pacific (rDENV1Δ30 -V181) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 7, March 29 2023, SOR/2023-50 |
Date published: | 2023-03-29 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant live-attenuated dengue virus serotype 2 modified from strain New Guinea C (rDENV2/4Δ30(ME)-V181) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 7, March 29 2023, SOR/2023-50 |
Date published: | 2023-03-29 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant live-attenuated dengue virus serotype 3 modified from strain Slemen/78 (rDENV3Δ30/31 -V181) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 7, March 29 2023, SOR/2023-50 |
Date published: | 2023-03-29 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant live-attenuated dengue virus serotype 4 modified from strain Dominica/81/814669 (rDENV4Δ30 -V181) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 7, March 29 2023, SOR/2023-50 |
Date published: | 2023-03-29 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant non-replicating adeno-associated virus serotype 6 vector encoding B-domain deleted human coagulation Factor VIII (PF-07055480) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 11, May 24 2023, SOR/2023-90 |
Date published: | 2023-05-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant non-replicating adeno-associated virus serotype 9 (AAV9) vector encoding human iduronate-2-sulfatase gene (RGX-121) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 1, January 4 2023, SOR/2022-270 |
Date published: | 2023-01-04 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant non-replicating Human adenovirus C, EI/E3 deleted, encoding for a human interferon alpha-2b cDNA driven by cytomegalovirus and adenovirus type 2 tripartite leader |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 154, No. 26, December 23 2020, SOR/2020-274 |
Date published: | 2020-12-23 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant non-replicating human adenovirus type 26 encoding the severe acute respiratory syndrome coronavirus 2 Spike protein (Ad26.COV2.S) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 155, No. 11, May 26, 2021, SOR/2021-98 |
Date published: | 2021-05-26 |
Substance identifier: | 19493-1 |
Substance identifier (2): | |
Substance name: | Recombinant paramyxovirus encoding transgene (MRK-RPET-001) |
Additional information: | This substance is a living organism. The Public Health Agency of Canada (PHAC) has classified this biological agent as a human and/or terrestrial animal pathogen. Under the Human Pathogens and Toxins Act (HPTA), controlled activities with human pathogens that are classified as Risk Group 2-4 require a licence, issued by PHAC. PHAC is also responsible for issuing permits for the importation of pure cultures of terrestrial animal pathogens of Risk Group 2-4, with the exception of non-indigenous animal pathogens and pathogens causing emerging animal disease, under the authority of the Health of Animal Regulations (HAR). For a listing of Risk Group classifications of biological agents in Canada, visit ePATHogen - Risk Group Database. Please contact pathogens.pathogenes@phac-aspc.gc.ca for further information. Please note: The Canadian Food Inspection Agency (CFIA) has the authority under the Health of Animals Act and the Health of Animals Regulations to issue importation permits for animals, animal products and by-products, aquatic animal pathogens, bee pathogens, pathogens causing foreign animal diseases, and pathogens causing emerging animal diseases. The CFIA also issues import permits for plant pests under the Plant Protection Act. |
Recent publication(s): | Canada Gazette Part II, Vol. 154, No. 26, December 23 2020, SOR/2020-274 |
Date published: | 2020-12-23 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant replication-defective chimpanzee adenovirus ChAdOx1 expressing the glycoprotein E gene from the varicella-zoster virus (ChAdOx1-VZV) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 25, December 6 2023, SOR/2023-252 |
Date published: | 2023-12-06 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant replication-defective chimpanzee adenovirus Ox1 expressing Spike protein (S protein) of SARS-CoV-2 (ChAdOx1-S) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 155, No. 14, July 7, 2021, SOR/2021-159 |
Date published: | 2021-07-07 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant replication-deficient adeno-associated viral vector serotype 2 expressing the human retinal pigment epithelium protein (rAAV2-hRPE65v2-LTW888) |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 11, May 24 2023, SOR/2023-90 |
Date published: | 2023-05-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Recombinant, chimeric vesicular stomatitis virus (VSV) carrying the envelope glycoprotein (GP) of the visceral non-neurotropic WE-HPI strain of the lymphocytic choriomeningitis virus, and a codon-optimized human CD80 gene fused to the Fc IgG1 heavy chain constant region |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 11, May 22, 2024, SOR/2024-83 |
Date published: | 2024-05-22 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Replication-incompetent chimpanzee-derived Simian mastadenovirus C serotype 155 expressing human respiratory syncytial virus A2 (HRSV-A2) antigens F, N and M2-1 |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 152, No. 26, December 26 2018, SOR/2018-271 |
Date published: | 2018-12-26 |
Substance identifier: | ATCC 17001 |
Substance identifier (2): | |
Substance name: | Rhodopseudomonas palustris |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 139, No. 25, December 14 2005, SOR/2005-412 |
Date published: | 2005-12-14 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Saccharomyces cerevisiae expressing lactate dehydrogenase (LDH) from Rhizopus oryzae |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 158, No. 9, April 24 2024, SOR/2024-56 |
Date published: | 2024-04-24 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Saccharomyces cerevisiae expressing pyruvate formate lyase activating enzyme, pyruvate formate lyase, and bifunctional acetaldehyde-CoA/alcohol dehydrogenase from Bifidobacterium adolescentis and a glucoamylase from Saccharomycopsis fibuligera |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 156, No. 1, January 5, 2022, SOR/2021-253 |
Date published: | 2022-01-05 |
Substance identifier: | 19289-7 |
Substance identifier (2): | |
Substance name: | Saccharomyces cerevisiae strain 17110219 containing gene XI from a foreign organism and additional copies of genes TAL1, TKL1, RPE1, RKI1 and XKS1 from Saccharomyces cerevisiae |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 152, No. 16, August 08, 2018, SOR/2018-163 |
Date published: | 2018-08-08 |
Substance identifier: | 19288-6 |
Substance identifier (2): | |
Substance name: | Saccharomyces cerevisiae strain 17110868 containing pflA, pflB, and adhE genes from a foreign organism, glucoamylase gene from a foreign organism, and the stl1 gene from Saccharomyces cerevisiae |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 152, No. 16, August 08, 2018, SOR/2018-163 |
Date published: | 2018-08-08 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Saccharomyces cerevisiae, Strain F53, Red Star Active Dry Yeast |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 139, No. 21, Octobre 19 2005, SOR/2005-301 |
Date published: | 2005-10-19 |
Substance identifier: | 19541-9 |
Substance identifier (2): | |
Substance name: | Saccharomyces species, MeJi797 |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 156, No. 1, January 5 2022, SOR/2021-261 |
Date published: | 2022-01-05 |
Substance identifier: | 19658-6 |
Substance identifier (2): | |
Substance name: | Saccharomyces species, S1077-H06 |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 11, May 24 2023, SOR/2023-90 |
Date published: | 2023-05-24 |
Substance identifier: | 19542-0 |
Substance identifier (2): | |
Substance name: | Saccharomyces species, yMHCT484 |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 156, No. 1, January 5 2022, SOR/2021-261 |
Date published: | 2022-01-05 |
Substance identifier: | ATCC 74252 |
Substance identifier (2): | |
Substance name: | Trichoderma reesei |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 155, No. 17, August 18, 2021, SOR 2021-183 |
Date published: | 2021-08-18 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Unmodified human embryonic stem cells derived pancreatic islet cells |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 157, No. 14, July 5 2023, SOR/2023-145 |
Date published: | 2023-07-05 |
Substance identifier: | |
Substance identifier (2): | |
Substance name: | Unmodified human-derived mesenchymal stromal cells |
Additional information: | This substance is a living organism. |
Recent publication(s): | Canada Gazette Part II, Vol. 154, No. 18, September 2, 2020, SOR/2020-176 |
Date published: | 2020-09-02 |